Doxorubicin (DOX) is one of most used chemotherapeutic drugs, but it has important adverse effects. Nutrition has a critical role to prevent or minimize chemotherapy side effects. Caloric and nutrient restriction has been widely studied in different health fields showing extensive beneficial effects. Given the importance of these interventions, it is expected that some of them have benefits in patients under DOX chemotherapy.
OBJECTIVE:
This review aimed to compile published studies evaluating the effects of different dietary intetrventions based on restriction of calories or certain nutrients against DOX-induced damage and toxicity.
RESULTS:
Caloric restriction and partial reduction of fat have shown to reduce DOX cardiotoxicity correlating with a reduction of oxidative stress. Reduction of dietary fat was proved to act in the same sense at liver and kidney. Studies in relation to protein reduction is more elevated has focused only on kidneys and bone, and under certain circumstances, these interventions could increase susceptibility to DOX toxicity.
CONCLUSIONS:
The promising effects of restriction of dietary fat, protein and sodium on differerent organs have been supported by a greater number of studies among all the dietary interventions evaluated. Still, clinical studies are necessary to confirm the potential usefulness of these interventions.
HilmerSN, CoggerVC, MullerM, Le CouteurDG. The hepatic pharmacokinetics of doxorubicin and liposomal doxorubicin. Drug Metab Dispos. 2004;32:794–9. https://doi.org/10.1124/dmd.32.8.794
2.
MinottiG, RecalcatiS, MennaP, et al. Doxorubicin cardiotoxicity and the control of iron metabolism: quinone-dependent and independent mechanisms. Methods Enzymol. 2004;378:340–61. https://doi.org/10.1016/S0076-6879(04)78025-8
Varela-LópezA, BattinoM, Navarro-HortalMD, et al. An update on the mechanisms related to cell death and 344 toxicity of doxorubicin and the protective role of nutrients. Food and Chemical Toxicology. 2019;134:110834. https://doi.org/10.1016/j.fct.2019.110834
7.
GiampieriF, AfrinS, Forbes-HernandezTY, et al. Autophagy in Human Health and Disease: Novel Therapeutic Opportunities. Antioxidants & Redox Signaling. 2019;30:577–634. https://doi.org/10.1089/ars.2017.7234
8.
CardinaleD, ColomboA, LamantiaG, et al. Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacologic therapy. J Am Coll Cardiol. 2010;55:213–20. https://doi.org/10.1016/j.jacc.2009.03.095
9.
PragaC, BerettaG, VigoPL, et al. Adriamycin cardiotoxicity: a survey of patients. Cancer Treatrep. 1979;63:827–34.
10.
SteinherzLJ, SteinherzPG, TanCT, et al. Cardiac toxicity 4 to 20 years after completing anthracycline therapy. JAMA. 1991;266:1672–7.
11.
WangX, WuG, LuC, et al. A novel delivery system of doxorubicin with high load and pH-responsive release from the nanoparticles of poly (α,β-aspartic acid) derivative. Eur J Pharm Sci. 2012;47:256–64. https://doi.org/10.1016/j.ejps.2012.04.007
KumarR, KulkarniA, NageshaDK, SridharS. In Vitro Evaluation of Theranostic Polymeric Micelles for Imaging and Drug Delivery in Cancer. Theranostics.2012;2:714–22. https://doi.org/10.7150/thno.3927
14.
ThornCF, OshiroC, MarshS, et al. Doxorubicin pathways: pharmacodynamics and adverse effects. Pharmacogenet Genomics. 2011;21:440–6. https://doi.org/10.1097/FPC.0b013e32833ffb56
15.
AfsarT, RazakS, AlmajwalA. Effect of Acacia hydaspica R. Parker extract on lipid peroxidation, antioxidant status, liver function test and histopathology in doxorubicin treated rats. Lipids Health Dis. 2019;18:. https://doi.org/10.1186/s12944-019-1051-2
16.
AliN, AlAsmariAF, ImamF, et al. Protective effect of diosmin against doxorubicin-induced nephrotoxicity. Saudi Journal of Biological Sciences. 2021; https://doi.org/10.1016/j.sjbs.2021.04.030
17.
SongS, ChuL, LiangH, et al. Protective Effects of Dioscin Against Doxorubicin-Induced Hepatotoxicity Via Regulation of Sirt1/FOXO1/NF-κb Signal. Front Pharmacol. 2019;10:. https://doi.org/10.3389/fphar.2019.01030
18.
KalenderY, YelM, KalenderS. Doxorubicin hepatotoxicity and hepatic free radical metabolism in rats: The effects of vitamin E and catechin. Toxicology. 2005;209:39–45. https://doi.org/10.1016/j.tox.2004.12.003
19.
AltinkaynakY, KuralB, AkcanBA, et al. Protective effects of L-theanine against doxorubicin-induced nephrotoxicity in rats. Biomed Pharmacother. 2018;108:1524–34. https://doi.org/10.1016/j.biopha.2018.09.171
20.
El-SayedE-SM, MansourAM, El-SawyWS. Alpha lipoic acid prevents doxorubicin-induced nephrotoxicity by mitigation of oxidative stress, inflammation, and apoptosis in rats. J Biochem Mol Toxicol. 2017;31. https://doi.org/10.1002/jbt.21940
21.
TacarO, SriamornsakP, DassCR. Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems. J Pharm Pharmacol. 2013;65:157–70. https://doi.org/10.1111/j.2042-7158.2012.01567.x
22.
NagaiK, FukunoS, OtaniK, et al. Prevention of Doxorubicin-Induced Renal Toxicity by Theanine in Rats. PHA. 2018;101:219–24. https://doi.org/10.1159/000486625
23.
RashidS, AliN, NafeesS, et al. Alleviation of doxorubicin-induced nephrotoxicity and hepatotoxicity by chrysin in Wistar rats. Toxicology Mechanisms and Methods. 2013;23:337–45. https://doi.org/10.3109/15376516.2012.759306
24.
AlemanBMP, MoserEC, NuverJ, et al. Cardiovascular disease after cancer therapy. European Journal of Cancer Supplements. 2014;12:18–28. https://doi.org/10.1016/j.ejcsup.2014.03.002
25.
CianciosiD, Forbes-HernándezTY, AnsaryJ, et al. Phenolic compounds from Mediterranean foods as nutraceutical tools for the prevention of cancer: The effect of honey polyphenols on colorectal cancer stem-like cells from spheroids. Food Chemistry. 2020;325:126881. https://doi.org/10.1016/j.foodchem.2020.126881
26.
AfrinS, GiampieriF, GasparriniM, et al. The inhibitory effect of Manuka honey on human colon cancer HCT-116 and LoVo cell growth. Part 1: the suppression of cell proliferation, promotion of apoptosis and arrest of the cell cycle. Food Funct. 2018;9:2145–57. https://doi.org/10.1039/C8FO00164B
27.
AfrinS, GiampieriF, GasparriniM, et al. Dietary phytochemicals in colorectal cancer prevention and treatment: A focus on the molecular mechanisms involved. Biotechnology Advances. 2020;38:107322. https://doi.org/10.1016/j.biotechadv.2018.11.011
28.
BattinoM, Forbes-HernándezTY, GasparriniM, et al. Relevance of functional foods in the Mediterranean diet: the role of olive oil, berries and honey in the prevention of cancer and cardiovascular diseases. Critical Reviews in Food Science and Nutrition. 2019;59:893–920. https://doi.org/10.1080/10408398.2018.1526165
SorensenJC, CheregiBD, TimpaniCA, et al. Mitochondria: Inadvertent targets in chemotherapy-induced skeletal muscle toxicity and wasting?Cancer Chemother Pharmacol. 2016;78:673–83. https://doi.org/10.1007/s00280-016-3045-3
31.
SorensenJC, PetersenAC, TimpaniCA, et al. BGP-15 Protects against Oxaliplatin-Induced Skeletal 396 Myopathy and Mitochondrial Reactive Oxygen Species Production in Mice. Front Pharmacol. 2017;8:. https://doi.org/10.3389/fphar.2017.00137
32.
ZiętarskaM, Krawczyk-LipiecJ, KrajL, et al. Chemotherapy-Related Toxicity, Nutritional Status and Quality of Life in Precachectic Oncologic Patients with, or without, High Protein Nutritional Support. A Prospective, Randomized Study. Nutrients. 2017;9:. https://doi.org/10.3390/nu9101108
33.
QuilesJL, Rivas-GarcíaL, Varela-LópezA, et al. Do nutrients and other bioactive molecules from foods have anything to say in the treatment against COVID-19?Environ Res. 2020;191:110053. https://doi.org/10.1016/j.envres.2020.110053
34.
QuilesJL, Sánchez-GonzálezC, Vera-RamírezL, et al. Reductive Stress, Bioactive Compounds, Redox-Active Metals, and Dormant Tumor Cell Biology to Develop Redox-Based Tools for the Treatment of Cancer. Antioxid Redox Signal. 2020;33:860–81. https://doi.org/10.1089/ars.2020.8051
35.
Navarro-HortalMD, Varela-LópezA, Romero-MárquezJM, et al. Role of flavonoids against adriamycin toxicity. Food and Chemical Toxicology. 2020;146:111820. https://doi.org/10.1016/j.fct.2020.111820
36.
FaccioAA, Mattos deCHP S, Santos EAS, et al. Oral Nutritional Supplementation in Cancer Patients Who Were Receiving Chemo/Chemoradiation Therapy: A Multicenter, Randomized Phase II Study. Nutrition and Cancer. 2021;73:442–9. https://doi.org/10.1080/01635581.2020.1758170
37.
Ramirez-TortosaCL, Varela-LópezA, Navarro-HortalMD, et al. Longevity and Cause of Death in Male Wistar Rats Fed Lifelong Diets Based on Virgin Olive Oil, Sunflower Oil, or Fish Oil. The Journals of Gerontology: Series A. 2020;75:442–51. https://doi.org/10.1093/gerona/glz091
38.
AndersonRM, ShanmuganayagamD, WeindruchR. Caloric restriction and aging: studies in mice and monkeys. Toxicol Pathol. 2009;37:47–51. https://doi.org/10.1177/0192623308329476
KitadaM, OguraY, MonnoI, et al. Effect of Methionine Restriction on Aging: Its Relationship to Oxidative Stress. Biomedicines. 2021;9:. https://doi.org/10.3390/biomedicines9020130
41.
López-TorresM, BarjaG. Lowered methionine ingestion as responsible for the decrease in rodent mitochondrial oxidative stress in protein and dietary restriction possible implications for humans. Biochim Biophys Acta. 2008;1780:1337–47. https://doi.org/10.1016/j.bbagen.2008.01.007
42.
PamplonaR, BarjaG. Mitochondrial oxidative stress, aging and caloric restriction: the protein and methionine connection. Biochim Biophys Acta. 2006;1757:496–508. https://doi.org/10.1016/j.bbabio.2006.01.009
43.
RamaiahSK, ApteU, MehendaleHM. Diet Restriction as a Protective Mechanism in Noncancer Toxicity Outcomes: A Review. Int J Toxicol. 2000;19:413–24. https://doi.org/10.1080/109158100750058776
MitraMS, DonthamsettyS, WhiteB, et al. Mechanism of protection of moderately diet restricted rats against doxorubicin-induced acute cardiotoxicity. Toxicology and Applied Pharmacology. 2007;225:90–101. https://doi.org/10.1016/j.taap.2007.07.018
46.
MongM, HsiaT, YinM. Dietary Trans Fats Enhance Doxorubicin-Induced Cardiotoxicity in Mice. Journal of Food Science. 2013;78:H1621–H1628. https://doi.org/10.1111/1750-3841.12257
47.
ZbindenG, BrändleE, PfisterM. Modification of adriamycin toxicity in rats fed a high fat diet. Agents Actions. 1977;7:163–70. https://doi.org/10.1007/BF01964915
48.
MitraM, DonthamsettyS, WhiteB, MehendaleH. High fat diet-fed obese rats are highly sensitive to doxorubicin-induced cardiotoxicity. Toxicology and Applied Pharmacology. 2008;231:413–22. https://doi.org/10.1016/j.taap.2008.05.006
49.
HydockDS, LienC-Y, JensenBT, et al. Switching to a low-fat diet attenuates the intensified doxorubicin cardiotoxicity associated with high-fat feeding. Cancer Chemother Pharmacol. 2013;71:1551–60. https://doi.org/10.1007/s00280-013-2154-5
50.
SongH, LiX, ZhuC, WeiM. Glomerulosclerosis in adriamycin-induced nephrosis is accelerated by a lipid-rich diet. Pediatr Nephrol. 2000;15:196–200. https://doi.org/10.1007/s004670000464
51.
SongH, LiX, WeiM, ZhuC. Effect of high-lipid diet on glomerular mesangial matrix in adriamycin-induced nephrotic rats. Chin Med Sci J. 2002;17:134–9.
52.
MilnerLS, WeiS, KazakoffP, et al. Synergistic effects of fish oil diet and dimethylthiourea in acute adriamycin nephrosis. Am JMed Sci. 1994;308:266–70. https://doi.org/10.1097/00000441-199411000-00002
53.
BarcelliUO, BeachDC, ThompsonB, et al. A diet containing n-3 and n-6 fatty acids favorably alters the renal phospholipids, eicosanoid synthesis and plasma lipids in nephrotic rats. Lipids. 1988;23:1059–63. https://doi.org/10.1007/BF02535652
54.
CusackBJ, YoungSP, LosekeVL, et al. Effect of a low-protein diet on doxorubicin pharmacokinetics in the rabbit. Cancer Chemother Pharmacol. 1992;30:145–8. https://doi.org/10.1007/BF00686407
55.
El-DemerdashE, AliAA, El-TaherDEM, HamadaFMA. Effect of low-protein diet on anthracycline pharmacokinetics and cardiotoxicity. J Pharm Pharmacol. 2012;64:344–52. https://doi.org/10.1111/j.2042-7158.2011.01413.x
56.
BenigniA, ZojaC, RemuzziA, et al. Role of renal prostaglandins in normal and nephrotic rats with diet-induced hyperfiltration. J Lab Clin Med. 1986;108:230–40.
57.
RemuzziG, ZojaC, RemuzziA, et al. Low-protein diet prevents glomerular damage in adriamycin-treated rats. Kidney Int. 1985;28:21–7. https://doi.org/10.1038/ki.1985.113
58.
GinevriF, GhiggeriGM, OlegginiR, et al. Low-protein diet and xanthine-metabolising enzymes in adriamycin nephrosis. Nephrol Dial Transplant 5 Suppl. 1990;1:63–5. https://doi.org/10.1093/ndt/5.suppl_1.63
59.
ChoiEJ, MayRC, BaileyJ, et al. Mechanisms of adaptation to proteinuria in adriamycin nephrosis. American Journal of Physiology-Renal Physiology. 1993;265:F257–F63. https://doi.org/10.1152/ajprenal.1993.265.2.F257
60.
TamakiK, OkudaS, AndoT, et al. TGF-β1 in glomerulosclerosis and interstitial fibrosis of adriamycin nephropathy. Kidney International. 1994;45:525–36. https://doi.org/10.1038/ki.1994.68
61.
LimAY, KimSY, LeeIS, ChoueR. Impaired Bone Formation with a High-Protein Diet in Rats with Adriamycin-Induced Nephrotic Syndrome. KBR. 2012;35:438–44. https://doi.org/10.1159/000336361
62.
NagashimaA, OkudaS, TamakiK, FujishimaM. IInfluence of a high salt diet on glomerular injury and the preventive effects of amiloride in adriamycin nephropathyI. Nephron. 1995;71:87–94. https://doi.org/10.1159/000188679
63.
ParkJ-S, KimS, JoCH, et al. Effects of Dietary Salt Restriction on Renal Progression and Interstitial Fibrosis in Adriamycin Nephrosis. KBR. 2014;39:86–96. https://doi.org/10.1159/000355782
64.
HiraiT, OkumuraK, NishimotoY, et al. Upregulation of renaleNOSby high-sodium diet facilitates hypertension in doxorubicin-treated rats through enhanced oxidative stress. Toxicology. 2006;225:81–9. https://doi.org/10.1016/j.tox.2006.05.013
65.
NakayamaK, IshidaN, ShiraneM, et al. Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell. 1996;85:707–20. https://doi.org/10.1016/s0092-8674(00)81237-4
66.
BenjellounAS, MervilleP, CambarJ, AparicioM. Effects of a low-protein diet on urinary glycosaminoglycan excretion in adriamycintreated rats. Nephron. 1993;64:242–8. https://doi.org/10.1159/000187321
